Based on the high positive rate of GNAS mutations in affected liver tissues and the later development of classic clinical characteristics, GNAS sequencing in liver tissues from the suspected MAS patients with cholestasis may greatly shorten the duration time from presentation to diagnosis when neonatal cholestasis is the first attack symptom without other classic clinical characteristics occurring at the same time. Here, GNAS is linked to cholestasis.